Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The vulvar microbiome in lichen sclerosus and high-grade intraepithelial lesions.
Pagan L, Huisman BW, van der Wurff M, Naafs RGC, Schuren FHJ, Sanders IMJG, Smits WK, Zwittink RD, Burggraaf J, Rissmann R, Piek JMJ, Henderickx JGE, van Poelgeest MIE. Pagan L, et al. Among authors: burggraaf j. Front Microbiol. 2023 Nov 29;14:1264768. doi: 10.3389/fmicb.2023.1264768. eCollection 2023. Front Microbiol. 2023. PMID: 38094635 Free PMC article.
Stereophotogrammetric three-dimensional photography is an accurate and precise planimetric method for the clinical visualization and quantification of human papilloma virus-induced skin lesions.
Rijsbergen M, Pagan L, Niemeyer-van der Kolk T, Rijneveld R, Hogendoorn G, Lemoine C, Meija Miranda Y, Feiss G, Bouwes Bavink JN, Burggraaf J, van Poelgeest MIE, Rissmann R. Rijsbergen M, et al. Among authors: burggraaf j. J Eur Acad Dermatol Venereol. 2019 Aug;33(8):1506-1512. doi: 10.1111/jdv.15474. Epub 2019 Mar 12. J Eur Acad Dermatol Venereol. 2019. PMID: 30720900 Free PMC article.
Results of phase 2 trials exploring the safety and efficacy of omiganan in patients with human papillomavirus-induced genital lesions.
Rijsbergen M, Rijneveld R, Todd M, Feiss GL, Kouwenhoven STP, Quint KD, van Alewijk DCJG, de Koning MNC, Klaassen ES, Burggraaf J, Rissmann R, van Poelgeest MIE. Rijsbergen M, et al. Among authors: burggraaf j. Br J Clin Pharmacol. 2020 Nov;86(11):2133-2143. doi: 10.1111/bcp.14181. Epub 2020 Sep 28. Br J Clin Pharmacol. 2020. PMID: 31755993 Free PMC article. Clinical Trial.
No effect of topical digoxin and furosemide for patients with actinic keratosis.
Huisman BW, Nené LEH, Linders FLL, Gambrah TK, van der Kolk TN, de Kam ML, Bavinck JNB, Burggraaf J, Feiss G, Rissmann R. Huisman BW, et al. Among authors: burggraaf j. J Eur Acad Dermatol Venereol. 2023 Feb;37(2):e172-e174. doi: 10.1111/jdv.18624. Epub 2022 Oct 8. J Eur Acad Dermatol Venereol. 2023. PMID: 36177541 No abstract available.
Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial.
Rousel J, Saghari M, Pagan L, Nădăban A, Gambrah T, Theelen B, de Kam ML, Haakman J, van der Wall HEC, Feiss GL, Niemeyer-van der Kolk T, Burggraaf J, Bouwstra JA, Rissmann R, van Doorn MBA. Rousel J, et al. Among authors: burggraaf j. Int J Mol Sci. 2023 Sep 20;24(18):14315. doi: 10.3390/ijms241814315. Int J Mol Sci. 2023. PMID: 37762625 Free PMC article. Clinical Trial.
295 results